During the past decade, Mid-Carolina Cardiology Research Division/Presbyterian Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital" are "Paroxysmal Supraventricular Tachycardia" (2 trials), "Coronary Restenosis" (1 trials) and "Coronary Stenosis" (1 trials). Many other conditions were trialed in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital" in a lesser frequency.

Most popular intervention types in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital" are "Device" (3 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aptar Pharma Nasal Spray Bidose System" (1 trials), "Brachytherapy (beta source)" (1 trials), "Etripamil" (1 trials), "Etripamil NS 70 mg" (1 trials) and "Express2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mid-Carolina Cardiology Research Division/Presbyterian Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mid-Carolina Cardiology Research Division/Presbyterian Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Carolina Cardiology Research Division/Presbyterian Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".